NEXTCHEM’s subsidiary KT Tech will provide the licensing and the process design package for its NX Reform™ hydrogen technology as part of the larger Dung Quat Refinery’s upgrading and expansion project in Vietnam This agreement includes also the supply of the proprietary steam methane reforming equipment during the plant’s construction phaseMILAN, Oct. 10, 2024 /PRNewswire/ — MAIRE announces that NEXTCHEM (Sustainable Technology Solutions), through its subsidiary KT Tech, hydrogen technologies licensor, has been awarded by Binh Son Refining and Petrochemical Joint Stock Company (BSR) the licensing and the Process Design Package (PDP) for a new hydrogen production unit, as part of the larger upgrading and expansion project of Dung Quat Refinery in Vietnam.

 
 
KT Tech will design the new hydrogen production unit with a capacity of 22,676 cubic metres per hour (Nm3/h), leveraging on its proprietary technology. This technology, which is part of NX Reform™ hydrogen technology portfolio enables cost-effective hydrogen production and offers the potential to reduce the carbon footprint by incorporating CO2 capture technology. It offers flexibility in feedstock and capacity, ensuring production adaptability. The solution is based on proven and widely adopted steam methane reforming methods, resulting in high operational efficiency. Once the project reaches the construction phase, KT TECH will also supply the proprietary equipment for the steam methane reforming process.
Alessandro Bernini, MAIRE CEO, commented, “We are proud of this important achievement, which confirms our excellent track-record in upgrading existing production plants to enhance efficiency and achieving lower consumptions, thanks to our leading technological know-how and unparalleled process engineering capabilities.”
Logo: https://mma.prnewswire.com/media/2379433/4631640/MAIRE_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/nextchem-maire-awarded-licensing-and-process-design-package-to-upgrade-bsrs-hydrogen-production-unit-in-vietnam-based-on-its-proprietary-nx-reform-technology-302273100.html

TAIPEI, Oct. 10, 2024 /PRNewswire/ — GIGABYTE, the world’s leading computer brand, proudly announces the launch of the AORUS Z890 series motherboards. These new series introduce the groundbreaking D5 Bionic Corsa, a suite of AI-enhanced innovations that span software, hardware, and firmware for peak performance and signal optimization. Along with upgraded user-friendly features, the AORUS Z890 series stands as the most powerful and intelligent platform for the latest Intel® Core™ Ultra processors.

At the core of the AORUS Z890 series is the D5 Bionic Corsa, an AI-enhanced technology for DDR5 memory. This revolutionary suite elevates DDR5 memory performance to an unprecedented 9500+ MT/s across seamlessly integrating software, hardware, and firmware. The AI SNATCH Engine intelligently infers the best DDR5 XMP memory and CPU configurations, boosting speeds by up to 20%. With XMP AI BOOST and CPU AI BOOST, users can achieve world-class overclocking performance with just one click. On the hardware side, AI-Driven PCB Design uses AI simulations to minimize signal reflection by 28.2%, ensuring signal integrity for peak performance across multiple layers. The sturdy VRM design, combined with DDR Wind Blade technology, reduces temperatures by up to 10°C for enhanced thermal efficiency. On the firmware side, “HyperTune BIOS” integrates AI-driven optimizations to fine-tune the Memory Reference Code (MRC), ensuring sustained high performance for both gaming and multitasking enthusiasts.
The AORUS Z890 series features user-friendly innovations to simplify building and upgrading processes. With WIFI EZ-PLUG, users can install the Wi-Fi antenna in just one second, avoiding traditional manual twisting. The lineup also includes PCIe EZ-Latch Plus for easy graphics card removal, M.2 EZ-Latch Plus, and M.2 EZ-Latch Click for tool-free M.2 SSD and heatsink installation. For a versatile addition, Sensor Panel Link provides an internal HDMI or Type-C connector for small display installation. Additionally, Wi-Fi 7 technology ensures ultra-fast wireless speeds and optimized connectivity with its directional ultra-high gain antenna.
With a diverse range of models, including XTREME, MASTER, PRO, ULTRA, and ELITE, the AORUS Z890 series caters to a wide range of users. For more information on the AORUS Z890 motherboards, please visit: https://bit.ly/GIGABYTE_Z890_Motherboards
Photo – https://mma.prnewswire.com/media/2526511/GIGABYTE_Unveils_AORUS_Z890_Motherboards_with_AI_Enhanced_Innovations_for_the_Latest_Intel__Core__Ul.jpg

View original content:https://www.prnewswire.co.uk/news-releases/gigabyte-unveils-aorus-z890-motherboards-with-ai-enhanced-innovations-for-the-latest-intel-core-ultra-processors-302271497.html

UTRECHT, The Netherlands, Oct. 10, 2024 /PRNewswire/ — Vitestro, the innovator behind the world’s first autonomous blood drawing device, is excited to announce the appointment of Dave Hickey, former Executive Vice President and President of BD’s Life Sciences Segment, to its Board of Directors as an independent board member. This addition strengthens the board’s diverse expertise as Vitestro continues to innovate in the healthcare technology sector.

 
Dave Hickey brings over 20 years of leadership experience in the healthcare and medical technology sectors. In his most recent role at BD, he oversaw the development of cutting-edge diagnostic solutions and successfully scaled the business in the US and globally. Notably, he led BD’s response during the COVID-19 pandemic, where he developed numerous rapid and molecular diagnostic tests in record time to support healthcare providers and patients worldwide. Prior to BD, Dave held various executive positions at Siemens Healthcare, contributing to advancements in diagnostics and specimen collection.
“I am truly excited to be joining the Vitestro team,” Dave Hickey says. “Smart automation and robotics have had such a positive impact in so many areas of medicine, and to now see Vitestro applying its autonomous blood drawing technology to the field of phlebotomy will be transformational.”
As Vitestro expands into the US market, Dave’s extensive knowledge of the diagnostic lab industry and his proven leadership in launching innovative diagnostic solutions will be instrumental in shaping the company’s next steps. His broad perspective on novel technologies and deep industry experience will be invaluable as Vitestro continues its mission to revolutionize phlebotomy with autonomous technology.
“We are absolutely thrilled to welcome Dave Hickey to Vitestro’s Board of Directors,” said Toon Overbeeke, CEO at Vitestro. “His exceptional track record and deep expertise in the healthcare sector are impressive and a perfect fit for our ambitious vision. Having someone of Dave’s caliber join our board is both an honor and a testament to the exciting path we are forging in revolutionizing phlebotomy.”
Dave Hickey joined Vitestro’s board alongside other industry leaders including Dr. Fred Moll, co-founder of Intuitive Surgical and Auris Health.
Please join us in welcoming Dave Hickey to Vitestro’s Board of Directors!
About Vitestro
Founded in 2017, Vitestro is committed to improving the blood draw experience for patients and clinicians. With its revolutionary autonomous blood draw technology and a team of more than 80 highly skilled specialists in medical robotics, artificial intelligence, imaging software, and healthcare commercialization, Vitestro is transforming the blood draw industry globally. Vitestro is based in Utrecht, The Netherlands.
For more information, visit https://vitestro.com.
Logo – https://mma.prnewswire.com/media/2490675/Vitestro_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/vitestro-welcomes-dave-hickey-to-board-of-directors-as-an-independent-board-member-302273067.html